a(chn)ƷQ | ʰÓø2wf |
ӢQ | Anti-ASAH2 |
Ҏ(gu) | 0.2ml/200μg |
ӢQ Anti-ASAH2
Q ʰÓø2w
e Acylsphingosine deacylase 2; ASAH2; ASAH2_HUMAN; BCDase; hCD; HNAC1; LCDase; MGC129777; mitochondrial ceramidase; N acylsphingosine amidohydrolase (non lysosomal ceramidase) 2; N acylsphingosine amidohydrolase 2; N CDase; N-acylsphingosine amidohydrolase 2; N-CDase; NCDase; Neutral ceramidase soluble form; Non lysosomal ceramidase; Non-lysosomal ceramidase.
1mg/1ml
Ҏ(gu) 0.2ml/200μg
wԴ Rabbit
¡ polyclonal
淴 Human, Mouse, Rat, Dog, Rabbit
a(chn)Ʒ һ
оI ߌW (jng)W ̖D(zhun)
predicted molecular weight: 86kDa
Lyophilized or Liquid
ԭ KLH conjugated synthetic peptide derived from human ASAH2
a(chn)Ʒ WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
IgG
affinity purified by Protein A
Һ 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
a(chn)Ʒ WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
ʯϞƬԭޏͣ
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
l Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
̣
Ҹα濹wwıoԵĿwҪҸβ濹ԭ̼wϵy(tng)a(chn)ĿwijF(xin)к͵w(ni)ҸβwowӢĺHBsAb
1헿-HBs
(1)ӷNҸɹĘ־
(2)-HBsԆrͣЕrخԷ
2c-HBc-HBeͬr
3cHBsAgͬr
(1)Ⱦ˲ͬҸβ
(2)ȾS׃Ҹβ
(3)߹ܵ£-HBsHBsAg
4̎ڿԭ-wӑB(ti)ƽA
ʰÓø2wfԭ :
1خԽY(ji)ϿԭwֱܽخԭİмͨҪawɼȹͬl(f)]Чԭ?q)²pȻwͨ^cصخԽY(ji)ֱӰl(f)]кͲá
2awIgMIgG1IgG2IgG3ͨ^(jng);aw۵IgAIgG4IgEͨ^;aw
3Y(ji)ϼͬeףɽY(ji)ϲͬNļcߑ
4ͨ^̥PճĤGIgGͨ^̥PM̥Ѫʹ̥γȻ
AIgAͨ^ճĤճĤֲȾߵҪء
5пԭԣwһN|(zh)Ҳд̙Cwa(chn)ߑܡͬвͬĿԭ
6wӵĵֿcһͬ͟ᣬ6070漴ƉNøʹ|(zh)׃Ե|(zh)ƉĿwwɱ}a(chn)ϳ@cѪгпwٽ(jng)伃
wb
1wЧrb\߀ί,Ƃ俹wĿĶҪ^ЧrͬĿԭƂĿw,ҪЧrһbЧrķܶ,ԇ,֬Uɢԇ,ø(lin)ԇõĿԭƂĿwһ㶼мsɵbЧrķ,Y^Ƃ俹wЧr,һͲí֬Uɢԇb
2wخbwخָcԭƿԭ|(zh)RewخԸ,Re͏خͨԽ淴ʁʾ淴ʿøԇyԲͬȿԭͽƿԭքe,ӋԵĽY(ji),IC50rĝ,ʽӋ㽻淴
ÿԭIC50Ȟpg/,һЩƿԭ|(zh)IC50ȎǟoFr,ʾ@һѪcԭ|(zh)Ľ淴ʽƞ0,ԓѪخ^
3wHָwͿԭY(ji)ϵι̶̳HĸߵɿԭӵĴС,wӵĽY(ji)λccԭQ֮gw(gu)͵ĺmțQھSֿԭwͺﷀ(wn)ķgКI,ˮI,(c)෴늺ɻĎ,AͿgHHͳ(sh)Kʾ,KĆλL/molwHĜywĺYx,_w;,CwľһԵȾҪx
HIV-1͇H˜Ʒ
֧ԭw IgGwzy|(zh)Ʒ
Swؿԭ
^w IgGwzy|(zh)Ʒ
ؽMԭ
^w IgMwzy|(zh)Ʒ
CԵԭ
_Ӳ IgGwzy|(zh)Ʒ
ؽM˰-11˜Ʒ
_Ӳ IgMwzy|(zh)Ʒ
AntiGABA A) Alpha1 Receptor extracellular)GABA A) Alpha1 w )w0.2 ml)
AntiGABA A) Alpha1 Receptor extracellular)ATTO488GABA A) Alpha1 w )ATTO488w50 ul)
Gab 1 (phospho Tyr627) Polyclonal AntibodyGab 1 (phospho Tyr627) ¡w
GAAP Antibody Golgi antiapoptotic protein Protein S1R Transmembrane BAX inhibitor motifcontaining protein 4 ZproteinGAAPw
Ga15/16 AntibodyG alpha binding proteinGa15/16w
G3BP Antibody ATPdependent DNA helicase VIIIG3BPw
G3BP1 (phospho Ser232) Polyclonal AntibodyG3BP1 (phospho Ser232) ¡w
GTSE1 Polyclonal AntibodyG2Sڱ_1 ¡w
SREC Polyclonal AntibodyFwɆT1 ¡w
FUS AntibodyF(xin)USF(xin)usion involved in t1216 in malignant liposarcomaTLSTranslocated in liposarcoma proteinPigpenPOMp75FUSw
˾I(y)ĿwwڻWо̌WW䷽ʹõļWƷa(chn)ƷƷ|(zh)ԽrݣNҎ(gu)ۺ